Abstract
The discovery of heteroaryl-phenyl-substituted pyrazole derivatives as canine selective COX-2 inhibitors is described. Structure-activity relationship (SAR) studies of this class of compounds led to the identification of compound 1 which demonstrated a canine whole blood COX-2 inhibitory IC50 of 12 nM and selectivity ratio of COX-1/COX-2 greater than 4000-fold.
MeSH terms
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis*
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
-
Cyclooxygenase 1 / metabolism
-
Cyclooxygenase 2 / metabolism
-
Cyclooxygenase 2 Inhibitors / chemical synthesis*
-
Cyclooxygenase 2 Inhibitors / pharmacology
-
Dogs
-
Inhibitory Concentration 50
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / pharmacology
-
Structure-Activity Relationship
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase 2 Inhibitors
-
Pyrazoles
-
Cyclooxygenase 1
-
Cyclooxygenase 2